Femasys Announces First 100 Women Treated in Pivotal

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
26
Femasys Announces First 100 Women Treated in Pivotal Clinical Trial with FemBloc® Permanent Contraceptive System

ATLANTA, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first 100 woman in the BLOC pivotal clinical trial received the FemBloc ® permanent contraceptive treatment.

FemBloc is a first-in-class non-surgical, permanent female contraception solution performed in a medical office setting without anesthesia or implants. FemBloc consists of a temporary biopolymer that initiates a wound healing response in the fallopian tubes to form a permanent closure with the patient’s own scar tissue. The biopolymer completely exits the uterine cavity and fallopian tubes naturally over time. FemBloc is designed to be the safest and most convenient permanent contraceptive solution for patients and physicians. A positive safety profile was demonstrated in the BLOC pilot study (n=49) with no reported serious or unanticipated adverse events.

The open-label, multi-center landmark BLOC pivotal trial will require treatment of 500 patients with FemBloc to establish efficacy and safety with the following primary endpoints for the study: pregnancy rate at one year (n=436) and successful confirmation at three months post treatment (n=500). Secondary endpoints are safety, satisfaction and comfort with a comparison to surgical tubal ligation (control arm, n=300) at the same time points, including long-term follow up annually for two to five years post market.

“FemBloc represents a revolutionary approach to permanent female contraception, providing an important alternative for those considering surgery or those who rely on other methods of birth control such as “the pill,” condoms or IUDs but desire a permanent option,” said Kathy Lee-Sepsick, Chief Executive Officer and President of Femasys. “This trial marks an important milestone for women’s healthcare as Femasys continues to build on its portfolio of innovative in-office gynecological solutions for women at every stage of their reproductive life in our efforts to challenge decades-old practices and standards of care to meet the needs and choices of today’s patients.”

Of the 38 million women in the U.S. currently using contraceptives, approximately 13 million do not intend to have any or more children, 1 yet the sole option for permanent contraception (surgical tubal ligation) is outdated with a notable risk profile. Roughly 700,000 women per year 1 in the U.S. elect to undergo surgery requiring admittance to the hospital, anesthesia and incisional risks, and surgical recovery time.

About   Femasys Femasys is a privately held medical technology company transforming women’s healthcare worldwide by developing a platform of innovative in-office gynecological solutions. Femasys’ flagship product, FemBloc® Permanent Contraceptive System, is based on the Company’s groundbreaking non-surgical technology that utilizes a temporary biopolymer to permanently close the fallopian tubes. FemBloc is designed to reduce risk and cost to patients and the healthcare system at large. Femasys’ reproductive health portfolio includes FemVue ® , a product approved for sale worldwide for the diagnosis of infertility, along with a pipeline of solutions designed to improve the standard of women’s healthcare in an office setting. The FemBloc Permanent Contraceptive System is not commercially available for sale. Femasys, FemBloc and FemVue are registered trademarks for Femasys Inc. All rights reserved.

For more information, please visit: www.Femasys.com .

CONTACTS: Media Inquiries: Darcie Robinson         ICR, Inc. 203-919-7905 Darcie.robinson@icrinc.com

Investor Relations: David Clair ICR, Inc. 646-277-1266 David.clair@icrinc.com

____________________ 1 Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. National health statistics reports; no 60. Hyattsville, MD: National Center for Health Statistics. 2012.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 249

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 272

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 231

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 207

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 432

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 211

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 367

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 285

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading

Top 5 Most Recently Viewed Articles

StorageVault Canada Inc. Declares Q4 Dividend for Stakeholders

Updated Category News Views 91

StorageVault Canada Inc. Declares Q4 Dividend Announcement In a recent announcement, StorageVault Canada Inc. (TSX: SVI) revealed a quarterly dividend of $0.002991 per common share. This dividend is set to be distributed on January 15, 2026, to all shareholders listed as of December 31, 2025, coinciding with the ex-dividend date also on December 31. This designation...

Continue Reading
Calm Tuesday for Major Cryptocurrencies: Insights and Updates

Updated Category News Views 165

Market Overview: Cryptocurrencies in Focus On a quieter Tuesday, major cryptocurrencies such as Bitcoin, Ethereum, and XRP are showing a notable degree of stability. Bitcoin is currently trading just below $87,000 as it contends with the influx of new altcoin spot ETFs entering the market. Key Price Movements As investors navigate the changing landscape, here are the...

Continue Reading
Current Legal Challenge for Sun Communities, Inc. Investors

Updated Category News Views 286

Understanding the Sun Communities, Inc. Class Action Recently, a significant alert regarding Sun Communities, Inc. has been brought to attention for its stockholders. A class action has been initiated against the company due to allegations of misleading investors about possible conflicts of interest. Sun Communities, Inc. (SUI), primarily recognized for its investments in...

Continue Reading
Seeking Justice: BHC Sierra Vista Hospital Faces Allegations

Updated Category News Views 368

Labor Law Violation Allegations Against BHC Sierra Vista Hospital BHC Sierra Vista Hospital, Inc. is currently facing serious allegations for failing to provide its employees with legally mandated meal and rest breaks during their shifts. This alleged neglect not only goes against the California Labor Code but also contributes to the unfortunate situation where employees...

Continue Reading
ZKH Group Limited Reports Q3 2025 Financial Performance Insights

Updated Category News Views 183

Overview of ZKH Group Limited's Financial Results ZKH Group Limited (NYSE: ZKH), a premier platform for maintenance, repair, and operations (MRO) procurement services, has announced its unaudited financial results for the third quarter of 2025. The company has shown resilience and adaptability amidst a challenging economic landscape, with significant operational...

Continue Reading